Nurix Therapeutics, Inc. (NASDAQ:NRIX) Given Average Rating of “Moderate Buy” by Brokerages
MarketBeatNurix Therapeutics, Inc. (NASDAQ:NRIX – Get Free Report) has been assigned an average rating of “Moderate Buy” from the fifteen ratings firms that are covering the company, Marketbeat Ratings reports. One analyst has rated the stock with a hold ratin…